SATT Conectus Alsace SAS:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:SATT Conectus Alsace SAS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10534
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
SATT Conectus Alsace SAS (Conectus Alsace), a subsidiary of SATT Association, is a technology transfer service provider. The company offers services such as single entry point, well-defined research collaborations, technology transfers, accessible technology platforms, license approach, indexing, sensitization and training; management of IP rights and commercialization; investment, skills mapping, monitoring, contract management, platform management, and others. It provides accessible technology platforms for assessment of client analyses and evaluations. The company serves researchers and deal makers in health and life sciences, chemicals materials, engineering sciences, information and communication technology areas. Conectus Alsace is headquartered in Strasbourg, France.

SATT Conectus Alsace SAS – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Lysogene Enters into Agreement with Institute of Genetics and Molecular and Cellular Biology (IGBMC) and SATT Conectus 10
Domain Therapeutics Enters into Partnership Agreements with Five SATTs 11
Conectus Alsace Enters into Co-Development Agreement with PEP-Therapy 13
Licensing Agreements 14
SATT Conectus Alsace Enters into License Agreement with Syndivia 14
SATT Conectus Alsace SAS – Key Competitors 15
SATT Conectus Alsace SAS – Key Employees 16
SATT Conectus Alsace SAS – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare, Key Facts 2
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SATT Conectus Alsace SAS, Deals By Therapy Area, 2012 to YTD 2018 8
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Lysogene Enters into Agreement with Institute of Genetics and Molecular and Cellular Biology (IGBMC) and SATT Conectus 10
Domain Therapeutics Enters into Partnership Agreements with Five SATTs 11
Conectus Alsace Enters into Co-Development Agreement with PEP-Therapy 13
SATT Conectus Alsace Enters into License Agreement with Syndivia 14
SATT Conectus Alsace SAS, Key Competitors 15
SATT Conectus Alsace SAS, Key Employees 16

List of Figures
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[SATT Conectus Alsace SAS:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Vietnam National Petroleum Group (PLX):企業の財務・戦略的SWOT分析
    Vietnam National Petroleum Group (PLX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Electricity Generation Company of Bangladesh Ltd:企業の戦略的SWOT分析
    Electricity Generation Company of Bangladesh Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competit …
  • Dominion Energy Inc (D):石油・ガス:M&Aディール及び事業提携情報
    Summary Dominion Energy, Inc. (Dominion), formerly Dominion Resources, Inc., is a producer and transporter of energy. It carries out the generation, transmission and distribution of electricity; transmission, distribution, storage and processing of gas; and LNG import and storage activities. The com …
  • Colonial Pipeline Co:石油・ガス:M&Aディール及び事業提携情報
    Summary Colonial Pipeline Co (Colonial) is an oil and gas company that distributes petroleum products. The company transports refined petroleum products such as gasoline, home-heating oil, kerosene, diesel fuels; and aviation fuel including jet fuel and military fuels. It provides services including …
  • Logitech International S.A.:企業の戦略・SWOT・財務情報
    Logitech International S.A. - Strategy, SWOT and Corporate Finance Report Summary Logitech International S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Regis Corporation (RGS):企業の財務・戦略的SWOT分析
    Regis Corporation (RGS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Birks Group Inc (BGI):企業の財務・戦略的SWOT分析
    Birks Group Inc (BGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Nabriva Therapeutics plc (NBRV):企業の財務・戦略的SWOT分析
    Summary Nabriva Therapeutics Plc (Nabriva) is a biopharmaceutical company that researches and develops antibiotics for the treatment of infections. The company offers product candidate such as Xenleta (lefamulin), CONTEPO (fosfomycin), being developed in both intravenous and oral formulations for th …
  • Bone Therapeutics SA (BOTHE):企業の財務・戦略的SWOT分析
    Summary Bone Therapeutics SA (Bone Therapeutics) is a cell therapy company that develops autologous and allogeneic cell therapy products. It offers pipeline products such as PREOB, an autologous osteoblastic cell therapy product used for the treatment of osteonecrosis and non-union fractures; and AL …
  • Central Alabama Electric Cooperative Inc:企業の戦略的SWOT分析
    Central Alabama Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • China Health Group Inc (8225):企業の財務・戦略的SWOT分析
    China Health Group Inc (8225) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Nuvelution Pharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Nuvelution Pharma Inc (Nuvelution Pharma) is a developer of late-stage clinical assets. The company offers research and development risk-sharing approach to pharmaceutical and biotechnology companies. It facilitates advancement of late-stage clinical assets where research and development bud …
  • EDF Renewable Energy Inc-エネルギー分野:企業M&A・提携分析
    Summary EDF Renewable Energy, Inc. (EDF Renewable Energy), formerly, enXco, Inc., is an integrated energy company. The company designs, develops, constructs and operates renewable energy projects in the biogas, biomass, hydro, solar, wind and marine energy sectors; and provides storage solutions. It …
  • Etiqa General Insurance Berhad:企業の戦略的SWOT分析
    Etiqa General Insurance Berhad - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Banca Transilvania S.A.:企業の戦略・SWOT・財務情報
    Banca Transilvania S.A. - Strategy, SWOT and Corporate Finance Report Summary Banca Transilvania S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • The National Petrochemical Co:企業の戦略的SWOT分析
    The National Petrochemical Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Korea Gas Corp (036460):企業の財務・戦略的SWOT分析
    Korea Gas Corp (036460) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • J.F. Shea Co Inc:企業の戦略・SWOT・財務分析
    J.F. Shea Co Inc - Strategy, SWOT and Corporate Finance Report Summary J.F. Shea Co Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Australis Oil & Gas Ltd (ATS):石油・ガス:M&Aディール及び事業提携情報
    Summary Australis Oil & Gas Ltd (Australis) is an oil and gas company that offers exploration, development and production of crude oil and natural gas reserves. The company operates reserves and large undeveloped resources. Its projects include Tuscaloosa Marine Shale (TMS) and Lusitanian Basin. Aus …
  • Shell Pakistan Ltd (SHEL):企業の財務・戦略的SWOT分析
    Summary Shell Pakistan Ltd (Shell Pakistan), a subsidiary of Royal Dutch Shell plc is an oil and gas company that markets petroleum products and compressed natural gas. The company operates through three segments such as retail, lubricants and aviation. It retail segment offers a range of fuels such …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆